A Companion Sample Collection Protocol to Support the Discovery of Breast Cancer Aberrations With Treatment of CDK4/6 Therapy/LEE011/Ribociclib
Phase of Trial: Phase III
Latest Information Update: 28 Jun 2017
At a glance
- Drugs Ribociclib (Primary) ; Letrozole
- Indications Breast cancer
- Focus Therapeutic Use
- Sponsors Novartis Pharmaceuticals
- 16 Jun 2017 Planned End Date changed from 15 Dec 2019 to 16 Dec 2019.
- 16 Jun 2017 Planned primary completion date changed from 15 Dec 2019 to 16 Dec 2019.
- 03 May 2017 Status changed from not yet recruiting to recruiting.